Ardent Health, Inc. reports developments for a healthcare provider serving growing mid-sized urban communities in the United States. Through its subsidiaries, the company operates acute care hospitals and other sites of care across six states, with recurring updates centered on patient volume, admissions, net patient service revenue, adjusted EBITDA, cash flow, guidance, and balance-sheet priorities.
Company news also covers management presentations at healthcare investor conferences, operational-efficiency initiatives such as the IMPACT program, payer and Exchange market dynamics, and technology investments in virtual care. Recent operating updates include enterprise use of AI-assisted virtual nursing, patient observation, and patient-safety monitoring to support clinical workflows across inpatient settings.
Ardent Health (NYSE: ARDT) will release first quarter 2026 results after market close on May 5, 2026. A conference call is scheduled for May 6, 2026 at 10:00 a.m. ET to review results and hold Q&A.
A webcast and presentation materials will be available in the Investor Relations section at ir.ardenthealth.com. Participants should register at least 15 minutes early. Dial-in and international access codes are provided; a teleconference replay is available through May 20, 2026.
Ardent Health (NYSE: ARDT) reported fourth-quarter and full-year 2025 results on March 4, 2026. 4Q25 revenue was $1.605 billion and adjusted EBITDA was $134 million; full-year 2025 revenue was $6.32 billion and adjusted EBITDA was $545 million. The company ended 2025 with $710 million cash and lease-adjusted net leverage of 2.5x.
Ardent reiterated 2026 guidance: revenue $6.4–6.7 billion, adjusted EBITDA $485–535 million, and expects $55 million of IMPACT program savings in 2026. A conference call is scheduled for March 5, 2026.
Ardent Health (NYSE: ARDT) announced management will participate in investor conferences in March 2026. Presentations include a fireside chat at Leerink on March 9, 2026 at 10:00 a.m. ET in Miami and a virtual fireside chat at KeyBanc with a webcast March 18, 2026 at 2:15 p.m. ET.
A live audio webcast and replays will be available in the Investor Relations section at ir.ardenthealth.com. Management will be available for one-on-one investor meetings for registered attendees; contact details for investor relations were provided.
Ardent Health (NYSE: ARDT) is partnering with hellocare.ai to deploy AI‑assisted virtual physician, nursing, patient observation and safety capabilities across more than 2,000 patient rooms. The rollout standardizes virtual nursing, AI monitoring for fall and pressure‑injury prevention, and aims to extend clinical capacity and operational efficiency.
The platform integrates AI monitoring, purpose‑built hardware and clinical workflows and builds on hellocare.ai’s footprint supporting over 100 health systems.
Ardent Health (NYSE: ARDT) will release fourth quarter and full year 2025 results after market close on Wednesday, March 4, 2026. A conference call and webcast to review results and take questions is scheduled for Thursday, March 5, 2026 at 10:00 a.m. ET.
Investors can access the live webcast and presentation materials in the Investor Relations section at ir.ardenthealth.com. Teleconference dial-in numbers and an access code are provided for live participation and a replay available through March 19, 2026.
Target (NYSE: TGT) received an unsolicited mini-tender offer from TRC Capital to buy up to 1,500,000 shares at $89.00 per share in cash, representing about 0.33% of outstanding shares. The offer is scheduled to expire one minute after 11:59 p.m. ET on October 6, 2025. Target is not affiliated with or endorsing TRC Capital or the offer and urges shareholders to obtain current market quotations, consult brokers or financial advisors, and review the offer terms before acting.
The release notes mini-tender offers seek under 5% of shares to avoid certain investor protections and cites SEC guidance warning investors that some mini-tenders may be below market prices.
Ardent Health (NYSE: ARDT) reported 3Q25 results for the quarter ended September 30, 2025. Total revenue was $1.58 billion (up 8.8% Y/Y; 11.7% ex-$43M accounting estimate change). Adjusted EBITDA rose 46.3% to $143M. The company recorded a $23M net loss vs. $26M net income in 3Q24. Operating cash flow was $154M vs. $90M a year ago. Ardent increased professional liability reserves by $54M related to New Mexico claims and took a $43M revenue reduction from an accounts receivable estimate change. Ardent reaffirmed 2025 revenue guidance and revised 2025 adjusted EBITDA to $530–$555M.
Ardent Health (NYSE: ARDT) will participate in the 2025 Stephens Annual Investment Conference in Nashville on Tuesday, Nov. 18, 2025. Management will take part in a fireside chat on Nov. 18, 2025 at 11:00 a.m. ET.
A live audio webcast and a replay will be available in the Investor Relations section at ir.ardenthealth.com. Management will also be available for one-on-one investor meetings during the conference. For meeting arrangements contact your Stephens sales representative or Dave Styblo at investor.relations@ardenthealth.com.
Ardent Health (NYSE: ARDT) will issue third quarter 2025 results after market close on Wednesday, November 12, 2025. A conference call to review results and host Q&A is scheduled for Thursday, November 13, 2025 at 9:00 a.m. ET. A live webcast and presentation materials will be available in the Investor Relations section at ir.ardenthealth.com. Listeners should access the site at least 15 minutes early to register and install any required audio software.
Teleconference details: North America toll-free 1-888-596-4144, international 1-646-968-2525, access code 4437657. Replay available through November 27, 2025 at North America toll-free 1-800-770-2030 or international 1-647-362-9199 using access code 4437657.
Ardent Health (NYSE: ARDT) has successfully amended and extended its $777.5 million Term Loan Facility. The amendment includes a 50 basis point reduction in the interest rate, from Term SOFR plus 2.75% to Term SOFR plus 2.25%, and extends the maturity to September 2032.
The refinancing is expected to generate annual interest savings of $3.9 million and provides enhanced financial flexibility for the healthcare provider to pursue strategic growth initiatives and community investments.